Q2 2019

Source filing unavailable

Q2 2019 · —

Revenue

$23.00K

no prior Q2 2018 on file

Net Income

-$4.95K

no prior Q2 2018 on file

EPS Diluted

$0.00

no prior Q2 2018 on file

Operating Income-$4,658—

Operating Cash Flowderived-$22,135—

Margins · derived

Same quarter

no prior Q2 2018 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR